CD8A and Lassa fever: This was in agreement with data published by Sakabe et al. [65], who isolated PBMCs from LF survivors from Nigeria and Sierra Leone and re-stimulated them with recombinant VSVs encoding parts of GP and NP, confirming LASV-GP- and LASV-NP-specific CD8+ T cell responses in 6/6 and 4/6 individuals, respectively.